Treatment of myocardial infarction and acute coronary syndrome
Eptifibatide
Structural features
SMILES
C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N
Sequence
XXGDWPC-NH2
Route of administration
IV
Terminal half-life
2.5 hours
Protein binding
0.25
Absorption and Bioavailability
-